Skip to content

Medpace

US · MEDP #1015 by market cap Listed 2016
610.54 -23.44 -3.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
  • Total institutional ownership fell 0.1 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
84.83% -0.12pp
Institutions
910 -4
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund66.02%
Individual/Insider18.66%
Hedge Fund9.95%
Public Company4.27%
Government Pension Fund1.98%
Private Company1.03%
Sovereign Wealth Fund0.81%
Family Office/Trust0.38%
Insurance Company0.25%

Top holders as of 2026-09-30

August Troendle 18.13% · 5.07M sh
BlackRock 9.16% · 2.56M sh
AQR Capital Management 4.95% · 1.39M sh
Vanguard Capital Management, LLC 4.12% · 1.15M sh
T. Rowe Price Group, Inc. 4.08% · 1.14M sh
Vanguard Portfolio Management, LLC 3.88% · 1.09M sh
State Street Global Advisors 2.55% · 714.32K sh
Geode Capital Management, LLC 2.55% · 712.42K sh
Invesco Capital Management LLC 1.82% · 508.78K sh
Arrowstreet Capital, Limited Partnership 1.79% · 499.80K sh
Baillie Gifford 1.69% · 473.21K sh
Wasatch Advisors LP 1.67% · 465.94K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 18 buys · 29 sells

NameRoleStake
August Troendle Chief Executive Officer 18.13%
Susan Burwig Former Officer 0.19%
Brian Carley Independent Director 0.10%
Stephen Ewald Chief Compliance Officer, General Counsel & Corporate Secretary 0.07%
Jesse Geiger Former President 0.05%
Kevin Brady Chief Financial Officer 0.05%
Cornelius McCarthy Independent Director 0.04%
Fred Davenport Lead Independent Director 0.02%
Robert Kraft Independent Director 0.00%
Brad Hansman Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-28 Stephen Ewald Chief Compliance Officer, General Counsel & Corporate Secretary Open Market Disposition -1,245 $690.00
2026-10-26 Susan Burwig Former Officer Open Market Disposition -19,672 $677.00
2026-10-26 Susan Burwig Former Officer Derivative Exercise and Sale -328 $166.73–677.00
2026-10-26 Susan Burwig Former Officer Intent to Sell (Form 144) -3,940 $677.00
2026-10-25 Susan Burwig Former Officer Intent to Sell (Form 144) -16,060 $677.00
2026-10-20 Susan Burwig Former Officer Derivative Exercise and Retained +2,700 $166.73
2026-10-11 Susan Burwig Former Officer Derivative Exercise and Retained +3,000 $166.73
2026-10-06 Susan Burwig Former Officer Derivative Exercise and Retained +2,000 $166.73
2026-09-29 Cornelius McCarthy Independent Director Derivative Exercise and Retained +28 --
2026-09-29 August Troendle Chief Executive Officer Open Market Disposition -48,667 $621.02–625.47
2026-09-29 Robert Kraft Independent Director Derivative Exercise and Retained +32 --
2026-09-29 Brian Carley Independent Director Derivative Exercise and Retained +36 --
2026-09-27 August Troendle Chief Executive Officer Open Market Disposition -2,564 $620.07–620.60
2026-09-23 August Troendle Chief Executive Officer Open Market Disposition -43,916 $621.33–628.64
2026-09-21 August Troendle Chief Executive Officer Open Market Disposition -70,901 $623.29–628.11
2026-09-16 August Troendle Chief Executive Officer Open Market Disposition -10,880 $620.40
2026-09-15 August Troendle Chief Executive Officer Open Market Disposition -24,741 $620.84–621.29
2026-09-14 Susan Burwig Former Officer Derivative Exercise and Retained +3,000 $166.73
2026-08-26 August Troendle Chief Executive Officer Open Market Disposition -650 $620.27
2026-08-25 August Troendle Chief Executive Officer Open Market Disposition -4,673 $620.03–620.38

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Medpace discussion 0 comments

Add a comment